GO:0140294 NAD DNA ADP-ribosyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140294 NAD DNA ADP-ribosyltransferase activity describes the catalysis of ADP-ribose transfer from NAD+ to a residue in double-stranded DNA.
• This activity is distinct from canonical protein ADP-ribosylation because the acceptor is DNA itself, not a protein residue.
• The bacterial enzyme Scabin is a well-characterized DNA-acting ADP-ribosyltransferase that modifies double-stranded DNA.
• Mammalian cells can reverse mono-ADP-ribosylation of DNA breaks, indicating that DNA ADP-ribosylation is a dynamic and regulated modification.
• NAD+ availability controls multiple ADP-ribosylation reactions, including PARP-dependent DNA repair and mitochondrial DNA repair.
• Studying GO:0140294 requires combining NAD+ biology, DNA damage assays, and CRISPR-based gene editing to dissect causal roles.
Description
NAD DNA ADP-ribosyltransferase activity (GO:0140294) is a molecular function defined as the catalysis of ADP-ribose transfer from NAD+ to a residue in double-stranded DNA. This activity places NAD+ at the center of DNA modification chemistry, extending the known roles of ADP-ribosylation beyond protein substrates. The reaction consumes NAD+ and covalently attaches an ADP-ribose moiety to DNA, creating a DNA-linked ADP-ribose adduct that can influence DNA structure, repair, and signaling. Researchers study this term because it connects three major areas: NAD+ metabolism, DNA damage responses, and reversible nucleic acid modification. The bacterial enzyme Scabin provided early biochemical evidence that a DNA-acting ADP-ribosyltransferase can directly modify double-stranded DNA. In mammalian systems, mono-ADP-ribosylation of DNA breaks has been shown to be reversible, suggesting that DNA ADP-ribosylation is not a dead-end lesion but a regulated modification. Because NAD+ levels decline with age and metabolic stress, the availability of this substrate may influence DNA ADP-ribosylation capacity. PARP1, a major NAD+-consuming enzyme, regulates DNA repair in an NAD-dependent manner, and its activity is modulated by nuclear metabolic enzymes such as IMPDH2. These findings make GO:0140294 a relevant function for understanding how NAD+ links metabolism to genome stability.
NAD DNA ADP-ribosyltransferase activity At A Glance
| GO ID | GO:0140294 |
|---|---|
| GO term | NAD DNA ADP-ribosyltransferase activity |
| Ontology | molecular_function |
| Synonym | None listed in QuickGO |
| Definition | Catalysis of the transfer of the ADP-ribose group of NAD+ to a residue in double-stranded DNA |
| Substrate | NAD+ and double-stranded DNA |
| Product | ADP-ribosylated DNA and nicotinamide |
| Major function | Covalent modification of double-stranded DNA using NAD+ as the ADP-ribose donor |
| Related activity | Protein ADP-ribosylation and poly(ADP-ribosyl)ation reactions |
| Representative enzyme | Scabin from Streptomyces scabies |
| Reversibility | Mono-ADP-ribosylation of DNA breaks can be reversed in mammalian cells |
What Is GO:0140294?
GO:0140294 NAD DNA ADP-ribosyltransferase activity is defined by QuickGO as the catalysis of the transfer of the ADP-ribose group of NAD+ to a residue in double-stranded DNA. In other words, the enzyme binds NAD+, cleaves the nicotinamide moiety, and covalently attaches the remaining ADP-ribose unit to a DNA residue within a double-stranded context. This is a molecular_function term, meaning it describes what the enzyme does at the chemical level rather than where it acts or which pathway it belongs to. The term does not specify a particular DNA sequence, a particular base, or a particular enzyme family; instead, it captures the catalytic capability of transferring ADP-ribose from NAD+ to double-stranded DNA. This distinguishes it from protein ADP-ribosyltransferases, which modify amino acid residues on proteins. The reaction is NAD+-dependent and therefore sensitive to cellular NAD+ availability.
Why Is NAD DNA ADP-ribosyltransferase activity Important in Cell Biology?
GO:0140294 is important because it defines a direct chemical link between NAD+ metabolism and DNA modification, a connection that has implications for genome stability, aging, and disease. NAD+ is a central redox and signaling metabolite, and its decline during aging or metabolic dysfunction can limit NAD+-dependent processes. If DNA ADP-ribosylation depends on NAD+ availability, then conditions that lower NAD+ may alter the landscape of DNA modifications and DNA repair capacity. The discovery that DNA ADP-ribosylation can be reversed suggests that cells actively regulate this modification, much like they regulate protein ADP-ribosylation. Understanding this activity may reveal new mechanisms by which bacteria modify host DNA or by which eukaryotic cells mark DNA damage. It also provides a conceptual framework for studying PARP1-dependent DNA repair, since PARP1 consumes NAD+ and regulates mitochondrial DNA repair in an NAD-dependent manner. Nuclear metabolic enzymes such as IMPDH2 can modulate PARP1 activity, further linking nucleotide metabolism to DNA damage responses.
• Defines a direct role for NAD+ in covalent DNA modification, linking metabolism to genome stability.
• Provides a mechanism for DNA-acting ADP-ribosyltransferases such as Scabin to modify double-stranded DNA.
• Suggests that DNA ADP-ribosylation is a reversible modification, based on evidence that mono-ADP-ribosylation of DNA breaks can be reversed.
• Connects to PARP1 biology, since PARP1 regulates DNA repair in an NAD-dependent manner.
• Links to NAD+ decline during aging, which may affect NAD+-dependent DNA modification reactions.
• Relevant to bacterial pathogenesis, as Scabin is a DNA-acting ADP-ribosyltransferase from Streptomyces scabies.
• Relevant to cancer biology through NAD+ metabolism and DNA repair pathways.
• Provides a rationale for studying nuclear NAD+ synthesis and salvage pathways in DNA damage responses.
• Supports research into reversible nucleic acid modifications as regulatory marks.
• Encourages development of assays that distinguish DNA ADP-ribosylation from protein ADP-ribosylation.
What Happens During NAD DNA ADP-ribosyltransferase activity?
NAD+ binding and cofactor positioning
In simple terms: The enzyme first grabs NAD+, the molecule that carries the ADP-ribose unit.
The reaction begins when the enzyme binds NAD+ in its active site. NAD+ serves as the ADP-ribose donor, and its binding positions the cofactor for cleavage of the nicotinamide moiety. Because NAD+ is the substrate, the reaction is sensitive to cellular NAD+ levels, which can decline with age or metabolic stress. Extracellular NAD+ can also enhance PARP-dependent DNA repair capacity, indicating that NAD+ availability influences DNA repair processes. Nuclear NAD+ metabolism, including enzymes such as IMPDH2, can modulate PARP1 activity and downstream DNA damage responses.
Cleavage of NAD+ and ADP-ribose transfer
In simple terms: The enzyme cuts NAD+ and attaches the ADP-ribose part onto DNA.
After NAD+ binding, the enzyme catalyzes the cleavage of the nicotinamide group from NAD+, generating an ADP-ribose intermediate that is transferred to a residue in double-stranded DNA. This step is the defining catalytic event of GO:0140294. The acceptor is DNA rather than a protein residue, distinguishing this activity from canonical protein ADP-ribosylation. Scabin has been shown to act as a DNA-acting ADP-ribosyltransferase, providing direct biochemical evidence for this transfer reaction. The resulting DNA-linked ADP-ribose adduct is a covalent modification of DNA.
Formation of ADP-ribosylated DNA
In simple terms: DNA now carries an ADP-ribose tag, which can change how DNA behaves.
The transfer reaction produces ADP-ribosylated DNA, in which an ADP-ribose moiety is covalently attached to a DNA residue. This modification can potentially alter DNA structure, protein-DNA interactions, and downstream repair or signaling events. In mammalian cells, mono-ADP-ribosylation of DNA breaks has been observed and can be reversed, suggesting that the modification is dynamic. The existence of reversal mechanisms implies that cells can remove DNA ADP-ribose marks, similar to how they reverse protein ADP-ribosylation. This reversibility is important because it suggests a regulatory rather than purely damaging role for DNA ADP-ribosylation.
Reversal and downstream consequences
In simple terms: The tag can be removed, and the cycle of adding and removing it may help cells respond to DNA damage.
Mono-ADP-ribosylation of DNA breaks is reversible in mammalian cells, indicating that dedicated or indirect mechanisms can remove ADP-ribose from DNA. Reversal allows the modification to function as a transient signal rather than a permanent lesion. This dynamic cycle may influence DNA repair, chromatin accessibility, and DNA damage signaling. PARP1, a major NAD+-consuming enzyme, regulates mitochondrial DNA repair in an NAD-dependent manner, linking NAD+ availability to DNA repair outcomes. Because PARP1 activity can be modulated by nuclear metabolic enzymes such as IMPDH2, the broader metabolic state of the cell can influence ADP-ribosylation-dependent processes.
Integration with NAD+ metabolism and DNA repair
In simple terms: The whole reaction depends on how much NAD+ the cell has and how DNA repair is organized.
NAD DNA ADP-ribosyltransferase activity is embedded in cellular NAD+ metabolism. NAD+ levels decline with age and metabolic dysfunction, and reversing this decline can ameliorate age-related metabolic dysfunction in model systems. Poly(ADP-ribosyl)ation has been linked to aging, further connecting NAD+-dependent ADP-ribosylation to organismal physiology. Extracellular NAD+ can enhance PARP-dependent DNA repair capacity independently of CD73 activity, showing that NAD+ availability can be manipulated to affect DNA repair. PARP1 regulates mitochondrial DNA repair in an NAD-dependent manner, demonstrating that NAD+-dependent ADP-ribosylation influences DNA repair beyond the nucleus. Together, these findings place GO:0140294 within a broader network of NAD+ biology and genome maintenance.
Key Genes Involved in GO:0140294 NAD DNA ADP-ribosyltransferase activity
The following genes and proteins are directly or functionally linked to NAD DNA ADP-ribosyltransferase activity, NAD+ metabolism, or DNA ADP-ribosylation processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Scabin | DNA-acting ADP-ribosyltransferase from Streptomyces scabies that modifies double-stranded DNA | Biochemical model for GO:0140294 catalytic mechanism |
| PARP1 | NAD+-consuming enzyme that regulates DNA repair, including mitochondrial DNA repair | Central to NAD-dependent DNA repair and ADP-ribosylation research |
| IMPDH2 | Nuclear enzyme that controls the DNA damage response by modulating PARP1 activity | Links nucleotide metabolism to PARP1-dependent DNA repair |
| CD38 | NAD+-consuming enzyme whose inhibition reverses tissue NAD+ decline | Modulates NAD+ availability for ADP-ribosylation reactions |
| CD73 | Ectoenzyme involved in extracellular NAD+ metabolism; extracellular NAD+ enhances PARP-dependent DNA repair independently of CD73 | Used to dissect NAD+ uptake and DNA repair capacity |
| NAMPT | Rate-limiting enzyme in the NAD+ salvage pathway, indirectly supporting NAD+-dependent reactions | Target for modulating NAD+ levels in DNA repair studies |
| NMNAT | NAD+ biosynthetic enzyme family that supports nuclear and mitochondrial NAD+ pools | Relevant to compartmentalized NAD+ supply for DNA ADP-ribosylation |
| PARG | Poly(ADP-ribose) glycohydrolase that reverses poly(ADP-ribosyl)ation | Counteracts ADP-ribosylation and may influence DNA ADP-ribose turnover |
| ARH3 | ADP-ribosylhydrolase that removes ADP-ribose from substrates | Candidate for reversing DNA ADP-ribosylation |
| TARG1 | ADP-ribosylhydrolase involved in reversing ADP-ribosylation | Potential regulator of DNA ADP-ribose removal |
| XRCC1 | DNA repair protein that functions in single-strand break repair | Downstream effector of NAD-dependent DNA repair |
| LIG3 | DNA ligase involved in mitochondrial and nuclear DNA repair | Relevant to PARP1-dependent mitochondrial DNA repair |
| POLG | Mitochondrial DNA polymerase | Used to study mitochondrial DNA repair in NAD-dependent contexts |
| TP53 | Tumor suppressor that coordinates DNA damage responses | Readout for DNA damage response activation |
| H2AX | Histone variant phosphorylated at DNA damage sites | Marker of DNA damage response activation |
| GAPDH | Glycolytic enzyme with NAD+-binding capacity | Control for NAD+ metabolism studies |
| SIRT1 | NAD+-dependent deacetylase | Competes for NAD+ with ADP-ribosyltransferases |
| SIRT3 | Mitochondrial NAD+-dependent deacetylase | Links mitochondrial NAD+ to DNA repair |
How Is NAD DNA ADP-ribosyltransferase activity Regulated?
NAD DNA ADP-ribosyltransferase activity is regulated primarily by the availability of its substrate, NAD+, and by the enzymes that synthesize or consume NAD+. NAD+ levels decline with age and metabolic dysfunction, and pharmacological inhibition of CD38 can reverse tissue NAD+ decline, thereby potentially influencing NAD+-dependent reactions. Extracellular NAD+ can enhance PARP-dependent DNA repair capacity independently of CD73 activity, showing that NAD+ supply can be manipulated to regulate DNA repair. PARP1 activity is modulated by nuclear IMPDH2, which controls the DNA damage response, indicating that nucleotide metabolism can regulate ADP-ribosylation-dependent processes. Poly(ADP-ribosyl)ation is also linked to aging, suggesting that organismal aging influences NAD+-dependent ADP-ribosylation. Reversal of mono-ADP-ribosylation of DNA breaks provides an additional layer of regulation by removing the modification. Together, these mechanisms create a regulatory network in which NAD+ metabolism, DNA damage signaling, and ADP-ribose turnover control the effective level of DNA ADP-ribosylation.
NAD DNA ADP-ribosyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PARP1 | DNA repair deficiency and cancer | PARP1 knockout cell lines with DNA damage assays |
| IMPDH2 | DNA damage response and nucleotide metabolism | IMPDH2 knockout or point-mutation cells treated with DNA-damaging agents |
| CD38 | Age-related metabolic dysfunction and NAD+ decline | CD38 inhibitor-treated or knockout mouse models |
| Scabin | Bacterial pathogenesis and DNA modification | Recombinant Scabin protein and bacterial infection models |
| PARG | ADP-ribosylation reversal and genome stability | PARG knockout cells with ADP-ribosylation assays |
Cancer and DNA repair deficiency
NAD DNA ADP-ribosyltransferase activity is conceptually linked to cancer through NAD+-dependent DNA repair pathways. PARP1 regulates DNA repair in an NAD-dependent manner, and its activity can be modulated by nuclear IMPDH2, which controls the DNA damage response. Extracellular NAD+ enhances PARP-dependent DNA repair capacity, suggesting that NAD+ availability can influence how cancer cells respond to DNA damage. Because ADP-ribosylation is reversible, defects in reversal enzymes could alter DNA repair fidelity and contribute to genomic instability. These connections make NAD+-dependent DNA modification relevant to cancer biology and to the development of DNA repair-targeted therapies.
Aging and metabolic dysfunction
NAD+ decline is a hallmark of aging and metabolic dysfunction, and reversing this decline can ameliorate age-related metabolic dysfunction in model systems. Poly(ADP-ribosyl)ation has been linked to aging, suggesting that NAD+-consuming ADP-ribosylation reactions contribute to age-related physiology. If DNA ADP-ribosylation depends on NAD+ availability, then age-related NAD+ decline could reduce this modification and alter DNA repair capacity. This creates a potential feedback loop in which DNA damage consumes NAD+, further lowering NAD+ levels and impairing repair. Understanding GO:0140294 in this context may inform interventions aimed at preserving NAD+ and genome stability during aging.
Bacterial pathogenesis and host DNA modification
Scabin is a DNA-acting ADP-ribosyltransferase from Streptomyces scabies, providing a bacterial model for GO:0140294. Bacterial ADP-ribosyltransferases often target host molecules to manipulate cellular processes, and a DNA-acting enzyme could directly modify host DNA. Studying Scabin can reveal how DNA ADP-ribosylation affects DNA structure and function. This knowledge may be relevant to understanding bacterial virulence strategies and to developing tools for controlled DNA modification. The reversibility of DNA ADP-ribosylation in mammalian cells suggests that host cells may counteract bacterial DNA modification.
Mitochondrial dysfunction and DNA repair
PARP1 regulates mitochondrial DNA repair in an NAD-dependent manner, linking NAD DNA ADP-ribosyltransferase activity conceptually to mitochondrial genome maintenance. Mitochondrial NAD+ pools are maintained by distinct biosynthetic enzymes, and their disruption could affect mitochondrial DNA repair. SIRT3, a mitochondrial NAD+-dependent deacetylase, also competes for NAD+ and may influence mitochondrial DNA repair capacity. Defects in mitochondrial DNA repair are associated with mitochondrial diseases and neurodegeneration, making this an important area for future research. Understanding how NAD+-dependent ADP-ribosylation affects mitochondrial DNA could reveal new therapeutic targets.
From NAD DNA ADP-ribosyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate NAD DNA ADP-ribosyltransferase activity? | CRISPR knockout cell line with NAD+ and DNA ADP-ribosylation assays |
| Does a specific catalytic residue mediate ADP-ribose transfer to DNA? | Point-mutation knock-in of the catalytic residue |
| Does a disease-associated variant alter DNA ADP-ribosylation? | Knock-in of the patient variant followed by DNA damage assays |
| Where does the enzyme act in the cell? | Tagged knock-in with fluorescent or epitope tag for imaging |
| Does overexpression of the enzyme increase DNA ADP-ribosylation? | Overexpression cell line with NAD+ supplementation |
| Can NAD+ availability modulate DNA repair capacity? | Cells treated with NAD+ precursors or CD38 inhibitors |
How to Study the NAD DNA ADP-ribosyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Recombinant ADP-ribosylation assay | Transfer of ADP-ribose from NAD+ to DNA | Confirming GO:0140294 activity of candidate enzymes |
| NAD+ quantification | Cellular or tissue NAD+ levels | Linking NAD+ availability to DNA ADP-ribosylation |
| Comet assay | DNA strand breaks | Measuring DNA damage and repair capacity |
| Gamma-H2AX staining | DNA damage response activation | Assessing PARP1-dependent DNA repair |
| Mitochondrial DNA repair assay | Mitochondrial DNA integrity | Testing NAD-dependent mitochondrial DNA repair |
| Mass spectrometry | ADP-ribosylated proteins and DNA adducts | Mapping ADP-ribosylation sites |
| CRISPR knockout screening | Gene requirement for DNA ADP-ribosylation | Identifying regulators of the modification |
| Fluorescent biosensors | Real-time NAD+ dynamics | Monitoring NAD+ changes during DNA damage |
Biochemical ADP-ribosylation assays
Biochemical assays using recombinant enzymes such as Scabin can directly measure ADP-ribose transfer from NAD+ to double-stranded DNA. These assays typically use radiolabeled or fluorescent NAD+ to detect covalent modification of DNA. They can distinguish DNA ADP-ribosylation from protein ADP-ribosylation by using protein-free DNA substrates. Such assays are essential for confirming that a candidate enzyme has GO:0140294 activity. They can also be used to test inhibitors or mutants that affect catalysis.
NAD+ quantification and metabolic profiling
Measuring cellular NAD+ levels is critical because NAD+ is the substrate for DNA ADP-ribosylation. NAD+ can be quantified by enzymatic cycling assays, mass spectrometry, or fluorescent biosensors. Pharmacological inhibition of CD38 can reverse tissue NAD+ decline, providing a way to manipulate NAD+ levels experimentally. Extracellular NAD+ can be added to culture media to enhance PARP-dependent DNA repair capacity. These methods help establish whether changes in DNA ADP-ribosylation are driven by NAD+ availability.
DNA damage and repair assays
DNA damage assays such as comet assays, gamma-H2AX staining, and mitochondrial DNA repair assays can measure downstream consequences of NAD+-dependent ADP-ribosylation. PARP1 regulates mitochondrial DNA repair in an NAD-dependent manner, so mitochondrial DNA repair assays are particularly relevant. IMPDH2 controls the DNA damage response by modulating PARP1 activity, making gamma-H2AX a useful readout. These assays can be combined with NAD+ manipulation to test causality. They are also useful for evaluating whether DNA ADP-ribosylation affects repair efficiency.
Proteomics and modification mapping
Mass spectrometry-based proteomics can identify ADP-ribosylated proteins and, with specialized methods, ADP-ribosylated DNA adducts. Reversible mono-ADP-ribosylation of DNA breaks has been detected in mammalian cells, and mapping these sites can reveal where DNA ADP-ribosylation occurs. Proteomic approaches can also identify the enzymes and hydrolases that regulate DNA ADP-ribosylation. Combining proteomics with CRISPR knockout models can establish which genes are required for the modification. These methods are powerful for discovering new components of the DNA ADP-ribosylation pathway.
How CRISPR Can Be Used to Study GO:0140294 NAD DNA ADP-ribosyltransferase activity
Knockout
CRISPR knockout of candidate genes such as PARP1, IMPDH2, or CD38 can test whether they are required for NAD DNA ADP-ribosyltransferase activity or its downstream effects. Knockout cells can be challenged with DNA-damaging agents and assayed for DNA ADP-ribosylation, NAD+ levels, and DNA repair capacity. For example, PARP1 knockout cells show defects in NAD-dependent mitochondrial DNA repair. IMPDH2 knockout cells have altered DNA damage responses due to changes in PARP1 activity. CD38 knockout or inhibition increases NAD+ levels, which can enhance NAD+-dependent processes. These models are essential for establishing causal roles of specific genes.
Point Mutation
Point-mutation knock-in can be used to dissect the catalytic mechanism of DNA ADP-ribosyltransferases such as Scabin. By mutating predicted catalytic residues, researchers can test whether ADP-ribose transfer to DNA is abolished. Point mutations can also model disease-associated variants in genes like PARP1 or IMPDH2 to determine whether they alter DNA repair capacity. These experiments provide mechanistic insight that knockout alone cannot achieve. They are particularly useful for separating catalytic activity from scaffolding functions.
Knock-in
Knock-in of tagged versions of enzymes such as PARP1 or Scabin allows visualization and purification of the modified proteins. Fluorescent tags can reveal where DNA ADP-ribosylation occurs in cells and how it changes after DNA damage. Epitope tags enable immunoprecipitation and mass spectrometry to identify interacting partners. Knock-in of reporter constructs can also be used to monitor DNA repair at specific loci. These models are valuable for linking molecular activity to cellular localization.
Overexpression
Overexpression of DNA-acting ADP-ribosyltransferases such as Scabin can increase DNA ADP-ribosylation levels and reveal downstream consequences. Overexpression of NAD+ biosynthetic enzymes can boost NAD+ levels and enhance NAD-dependent DNA repair. Overexpression of PARP1 can sensitize cells to DNA damage by consuming NAD+. These models are useful for gain-of-function studies and for testing whether increased activity is sufficient to alter DNA repair. They can also be combined with NAD+ supplementation to maximize effects.
How EDITGENE Supports NAD DNA ADP-ribosyltransferase activity Research
Researchers studying NAD DNA ADP-ribosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in DNA modification, DNA repair, or NAD+ metabolism. EDITGENE provides CRISPR-based cell model services that enable precise genetic manipulation to answer these questions.
Contact EDITGENE today to design your custom CRISPR model for NAD DNA ADP-ribosyltransferase activity research.
Frequently Asked Questions About NAD DNA ADP-ribosyltransferase activity
What is NAD DNA ADP-ribosyltransferase activity?
NAD DNA ADP-ribosyltransferase activity (GO:0140294) is the catalysis of the transfer of the ADP-ribose group of NAD+ to a residue in double-stranded DNA.
What genes are involved in NAD DNA ADP-ribosyltransferase activity?
Genes and proteins linked to this activity include Scabin, PARP1, IMPDH2, CD38, and ADP-ribosylhydrolases such as PARG and ARH3.
What is the GO ID for NAD DNA ADP-ribosyltransferase activity?
The GO ID is GO:0140294, and the ontology aspect is molecular_function.
How is NAD DNA ADP-ribosyltransferase activity different from protein ADP-ribosylation?
Protein ADP-ribosylation modifies amino acid residues on proteins, whereas GO:0140294 specifically transfers ADP-ribose to a residue in double-stranded DNA.
Which enzyme is a known example of a DNA-acting ADP-ribosyltransferase?
Scabin from Streptomyces scabies is a well-characterized DNA-acting ADP-ribosyltransferase that modifies double-stranded DNA.
Is DNA ADP-ribosylation reversible?
Yes, mono-ADP-ribosylation of DNA breaks has been shown to be reversible in mammalian cells.
How does NAD+ availability affect DNA ADP-ribosylation?
NAD+ is the substrate for the reaction, so changes in NAD+ levels can affect DNA ADP-ribosylation capacity.
What diseases are linked to NAD DNA ADP-ribosyltransferase activity?
This activity is conceptually linked to cancer, aging, metabolic dysfunction, and mitochondrial DNA repair defects through NAD+ metabolism and DNA repair pathways.
How can CRISPR be used to study NAD DNA ADP-ribosyltransferase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models can test whether specific genes regulate DNA ADP-ribosylation and DNA repair.
What methods are used to measure NAD DNA ADP-ribosyltransferase activity?
Biochemical ADP-ribosylation assays, NAD+ quantification, DNA damage assays, and mass spectrometry are commonly used.
Conclusion
NAD DNA ADP-ribosyltransferase activity (GO:0140294) defines a direct chemical link between NAD+ metabolism and covalent modification of double-stranded DNA. This activity is exemplified by the bacterial enzyme Scabin and is conceptually connected to mammalian NAD+-dependent DNA repair processes involving PARP1 and IMPDH2. The reversibility of DNA ADP-ribosylation suggests that it is a regulated modification with potential signaling roles. Because NAD+ levels decline with age and metabolic dysfunction, this activity may be relevant to aging, cancer, and mitochondrial disease. Continued research using CRISPR models and biochemical assays will clarify how DNA ADP-ribosylation contributes to genome stability and human disease.
References
- 1. Espinar L et al.. 2024. Nuclear IMPDH2 controls the DNA damage response by modulating PARP1 activity.. Nat Commun 15(1):9515 PMID: 39532854
- 2. Tarragó MG et al.. 2018. A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD(+) Decline.. Cell Metab 27(5):1081-1095.e10 PMID: 29719225
- 3. Lyons B et al.. 2016. Scabin, a Novel DNA-acting ADP-ribosyltransferase from Streptomyces scabies.. J Biol Chem 291(21):11198-215 PMID: 27002155
- 4. Bürkle A et al.. 2004. Poly(ADP-ribosyl)ation and aging.. Exp Gerontol 39(11-12):1599-601 PMID: 15582275
- 5. Wilk A et al.. 2020. Extracellular NAD(+) enhances PARP-dependent DNA repair capacity independently of CD73 activity.. Sci Rep 10(1):651 PMID: 31959836
- 6. Herrmann GK et al.. 2021. Poly(ADP-ribose) polymerase 1 regulates mitochondrial DNA repair in an NAD-dependent manner.. J Biol Chem 296:100309 PMID: 33482196
- 7. Shall S. 1995. ADP-ribosylation reactions.. Biochimie 77(5):313-8 PMID: 8527483
- 8. Munnur D et al.. 2017. Reversible mono-ADP-ribosylation of DNA breaks.. FEBS J 284(23):4002-4016 PMID: 29054115
